The Prophylaxis Kakkonto Prevents the Onset of the Influenza Virus Among Pregnant Women After Contacting Infected Influenza Families

Abstract

The goal is to evaluate the efficacy of Kakkonto in the pregnant women who contacted the family member with influenza. Five pregnant women who did not want to take anti-influenza drugs were enrolled in this study. The pregnant weeks were : 5 weeks (Case A), 7 weeks (Case B), 8 weeks (Case C), 11 weeks (Case D), and 31 weeks (Case E), respectively. There was 1 infected influenza kid with (A) pregnant woman, and, there were 4 infected influenza husbands with another pregnant women. Study design was that these women took 7.5 g Kakkonto/5 days after contacting infected influenza families. After 3 weeks, Case A, who contacted a kid with influenza, had a fever up to 38 ℃. However, twice influenza tests showed negative. Other 4 cases (B, C, D, and E) had neither fever nor any kind of symptom. Finally, there were no side effect sign among these women and their neonatal babies. Kakkonto may prevent the onset of influenza among pregnant women who contacted the family member with influenza.